ResMed Inc. (RME.F)
- Previous Close
221.70 - Open
216.20 - Bid 218.90 x 20000
- Ask 220.50 x 20000
- Day's Range
216.20 - 220.90 - 52 Week Range
162.65 - 248.90 - Volume
34 - Avg. Volume
7 - Market Cap (intraday)
33.089B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
27.75 - EPS (TTM)
7.96 - Earnings Date Jul 30, 2025 - Aug 4, 2025
- Forward Dividend & Yield 1.88 (0.85%)
- Ex-Dividend Date May 8, 2025
- 1y Target Est
--
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
www.resmed.co.inRecent News: RME.F
View MorePerformance Overview: RME.F
Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RME.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RME.F
View MoreValuation Measures
Market Cap
33.21B
Enterprise Value
33.13B
Trailing P/E
27.83
Forward P/E
23.81
PEG Ratio (5yr expected)
1.48
Price/Sales (ttm)
7.28
Price/Book (mrq)
6.56
Enterprise Value/Revenue
7.38
Enterprise Value/EBITDA
21.12
Financial Highlights
Profitability and Income Statement
Profit Margin
26.15%
Return on Assets (ttm)
14.01%
Return on Equity (ttm)
25.81%
Revenue (ttm)
5.02B
Net Income Avi to Common (ttm)
1.31B
Diluted EPS (ttm)
7.96
Balance Sheet and Cash Flow
Total Cash (mrq)
944.84M
Total Debt/Equity (mrq)
15.14%
Levered Free Cash Flow (ttm)
1.2B